欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/1403/001
药品名称Doxorubicine hydrochloride 2 mg/ml PCH
活性成分
    • Doxorubicin hydrochloride 2.0 mg/ml
剂型Solution for injection
上市许可持有人Pharmachemie B.V. Swensweg 5 2031 GA Haarlem The Netherlands
参考成员国 - 产品名称Netherlands (NL)
Doxorubicine hydrochloride 2 mg/ml PCH, concentraat voor oplossing voor infusie
互认成员国 - 产品名称
    • Germany (DE)
      Doxorubicinhydrochlorid Teva 2mg/ml Solution for Injection
    • Denmark (DK)
    • Belgium (BE)
    • Luxembourg (LU)
    • Ireland (IE)
    • Italy (IT)
    • Czechia (CZ)
      Doxorubicin-Teva 0,2%
    • Slovenia (SI)
      Doksorubicin Teva 2 mg/ml koncentrat za raztopino za infundiranje
许可日期2009/09/06
最近更新日期2025/02/11
药物ATC编码
    • L01DB01 doxorubicin
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase